pI: 6.7114 |
Length (AA): 706 |
MW (Da): 78554 |
Paralog Number:
1
Signal peptide: Y | GPI Anchor: | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128467)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G01610 | cell division cycle 48C protein |
Babesia bovis | BBOV_IV011460 | ATPase AAA type domain containing protein |
Brugia malayi | Bm1_47170 | ATPase, AAA family protein |
Candida albicans | CaO19.11695 | Member of the AAA family of ATPases |
Candida albicans | CaO19.4219 | Member of the AAA family of ATPases |
Caenorhabditis elegans | CELE_Y48C3A.7 | Protein MAC-1 |
Cryptosporidium hominis | Chro.50178 | AAA ATPase |
Cryptosporidium parvum | cgd5_2010 | nuclear VCP like protein with 2 AAA ATpase domains |
Dictyostelium discoideum | DDB_G0282181 | AAA ATPase domain-containing protein |
Drosophila melanogaster | Dmel_CG8571 | smallminded |
Entamoeba histolytica | EHI_091060 | ATPase, AAA family protein |
Giardia lamblia | GL50803_42442 | Transitional endoplasmic reticulum ATPase |
Homo sapiens | ENSG00000143748 | nuclear VCP-like |
Leishmania braziliensis | LbrM.27.1140 | vesicular transport protein (CDC48 homologue), putative |
Leishmania donovani | LdBPK_270920.1 | vesicular transport protein (CDC48 homologue), putative |
Leishmania infantum | LinJ.27.0920 | vesicular transport protein (CDC48 homologue), putative |
Leishmania major | LmjF.27.1050 | vesicular transport protein (CDC48 homologue), putative |
Leishmania mexicana | LmxM.27.1050 | vesicular transport protein (CDC48 homologue), putative |
Loa Loa (eye worm) | LOAG_07685 | ATPase |
Mus musculus | 67459 | nuclear VCP-like |
Neospora caninum | NCLIV_031210 | ATPase, AAA family domain-containing protein, putative |
Oryza sativa | 4339880 | Os06g0109400 |
Plasmodium berghei | PBANKA_1221600 | cell division cycle ATPase, putative |
Plasmodium falciparum | PF3D7_0711000 | AAA family ATPase, CDC48 subfamily |
Plasmodium knowlesi | PKNH_0109700 | cell division cycle ATPase, putative |
Plasmodium yoelii | PY05787 | putative cell division cycle ATPase |
Saccharomyces cerevisiae | YLL034C | putative AAA family ATPase RIX7 |
Schmidtea mediterranea | mk4.048964.00 | |
Trypanosoma brucei gambiense | Tbg972.11.1760 | vesicular transport protein (CDC48 homologue), putative |
Trypanosoma brucei | Tb427tmp.55.0014 | vesicular transport protein (CDC48 homologue), putative |
Trypanosoma brucei | Tb927.11.1660 | vesicular transport protein (CDC48 homologue), putative |
Trypanosoma congolense | TcIL3000.11.1440 | vesicular transport protein (CDC48 homologue), putative |
Trypanosoma cruzi | TcCLB.506629.80 | vesicular transport protein (CDC48 homologue), putative |
Theileria parva | TP01_1158 | AAA family ATPase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.55.0014 this record | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.55.0014 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.55.0014 this record | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb11.55.0014 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y48C3A.7 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_Y48C3A.7 | Caenorhabditis elegans | sterile | wormbase |
YLL034C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1221600 | Plasmodium berghei | Essential | plasmo |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | increased (PATO:0000470) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2
1 literature reference was collected for this gene.